MCID: SPR012
MIFTS: 33

Separation Anxiety Disorder malady

Category: Mental diseases

Aliases & Classifications for Separation Anxiety Disorder

About this section

Aliases & Descriptions for Separation Anxiety Disorder:

Name: Separation Anxiety Disorder 11 13 68
 
Separation Anxiety Disorder of Childhood 68

Classifications:



External Ids:

Disease Ontology11 DOID:10685
ICD1030 F93.0

Summaries for Separation Anxiety Disorder

About this section
Disease Ontology:11 An anxiety disorder that involves the feeling of excessive and inappropriate levels of anxiety over being separated from a person to whom the individual has a strong emotional attachment or place.

MalaCards based summary: Separation Anxiety Disorder, also known as separation anxiety disorder of childhood, is related to personality disorder and autism spectrum disorder. An important gene associated with Separation Anxiety Disorder is DRD4 (Dopamine Receptor D4). Affiliated tissues include eye, and related mouse phenotypes are nervous system and behavior/neurological.

Wikipedia:71 Separation anxiety disorder (SAD), is an anxiety disorder in which an individual experiences excessive... more...

Related Diseases for Separation Anxiety Disorder

About this section

Graphical network of the top 20 diseases related to Separation Anxiety Disorder:



Diseases related to separation anxiety disorder

Symptoms & Phenotypes for Separation Anxiety Disorder

About this section

MGI Mouse Phenotypes related to Separation Anxiety Disorder according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00036317.0DRD4, EPRS, GTF2I, HTR7, OXT, PHGDH
2MP:00053866.8ADAD2, CORT, DRD4, GTF2I, HTR7, LTBP3

Drugs & Therapeutics for Separation Anxiety Disorder

About this section

Drugs for Separation Anxiety Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 100)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
CitalopramapprovedPhase 4, Phase 151259729-33-82771
Synonyms:
1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile
1,3-dihydro[3,4]benzofuran-5-carbonitrile
1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile
59729-33-8
AB00513896
AC-12214
AC1L1EFH
AE-641/00603021
Akarin
BPBio1_000929
BRD-A47598013-004-02-0
BSPBio_000843
Bonitrile
C07572
C20H21FN2O
CHEBI:3723
CHEMBL549
CID2771
CPD000465669
Celapram
Celexa
Celius
Ciazil
Cilift
Cipram
Cipramil
Ciprapine
Citabax
Citadur
Citadur (TN)
Citalec
Citalopram (USP/INN)
Citalopram Hydrobromide
Citalopram [Celexa]
Citalopram [INN:BAN]
Citalopram hydrobromide
Citalopramum
Citalopramum [INN-Latin]
 
Citol
Citopam
Citox
Citrol
Cytalopram
D07704
DB00215
Dalsan
EINECS 261-891-1
Elopram
HMS2090O09
HMS2093A14
Humorup
I01-0382
InChI=1/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3
L001223
LS-84327
Lopac0_000258
Lu 10-171
Lu-10-171
MolPort-003-666-794
NCGC00015267-07
NCGC00025160-02
Nitalapram
Oropram
Pramcit
Prestwick3_000692
Recital
SAM002589960
ST069372
STL058639
Seropram
Talam
Talohexal
Temperax
UNII-0DHU5B8D6V
Vodelax
Zentius
Zetalo
[3H]Citalopram
citalopram
2
Midazolamapproved, illicitPhase 4, Phase 3, Phase 2, Phase 172359467-70-84192
Synonyms:
4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate
59467-70-8
8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5a][1,4]benzodiazepine hydrochloride
8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine
8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine
AC-18749
AC1L1HMA
BIDD:GT0647
BRN 0625572
Buccolam
C07524
C18H13ClFN3
CHEMBL655
CID4192
D00550
DB00683
DEA No. 2884
Dazolam
Dea No. 2884
 
Dormicum
Dormicum (TN)
EINECS 261-774-5
LS-77780
Midanium
Midazolam
Midazolam (JAN/INN)
Midazolam Base
Midazolam Hcl
Midazolam [INN:BAN:JAN]
Midazolamum
Midazolamum [INN-Latin]
Midosed
MolPort-003-849-219
NCGC00168254-01
Ro 21-3981
TL8003787
UC429_SIGMA
UNII-R60L0SM5BC
Versed
ZINC00001732
midazolam
nchembio747-comp32
3
SertralineapprovedPhase 4, Phase 329979617-96-268617
Synonyms:
(+)-Sertraline
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
(1S,4S)-sertraline
(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine
79559-97-0 (Hydrochloride)
79617-96-2
AB00514002
AB1004870
AC-15639
AC1L2A41
AC1Q3O5N
AC1Q3XJU
Apo-Sertraline
BIDD:GT0768
BIDD:PXR0193
BPBio1_001285
BRD-K82036761-003-02-1
BRN 5753709
BSPBio_001167
BSPBio_002698
C07246
C17H17Cl2N
CHEBI:9123
CHEMBL809
CID68617
Cp 51974
D02360
DB01104
DB08567
FT-0081122
HSDB 7037
KBio3_001918
 
KBioGR_001724
LS-94179
Lustral
MLS001195647
MLS002222308
MolPort-002-885-860
NCGC00092386-03
NCGC00092386-04
NCGC00092386-05
NCGC00092386-06
NCGC00092386-07
NCGC00092386-08
NCGC00092386-09
Prestwick3_001014
SMR000596516
SPBio_000385
SRE
Sertralina
Sertralina [Spanish]
Sertraline
Sertraline (INN)
Sertraline Hydrochloride
Sertraline [INN:BAN]
Sertraline [Zoloft]
Sertraline hydrochloride
Sertralinum
Sertralinum [Latin]
Spectrum2_000493
Spectrum3_001079
Spectrum4_001232
Sultamicillin Tosylate
UNII-QUC7NX6WMB
Zoloft
cis-(+)-sertraline
sertraline
sertraline (Zoloft)
4
Gabapentinapproved, investigationalPhase 430360142-96-33446
Synonyms:
1-(Aminomethyl)-cyclohexaneacetic acid
1-(Aminomethyl)cyclohexaneacetic acid
2-[1-(aminomethyl)cyclohexyl]acetic acid
60142-96-3
AC-1485
AC1L1FYE
AC1Q53PH
AKOS000280865
Aclonium
Apo-Gabapentin
Apotex brand of gabapentin
Aventis brand of gabapentin
BB_SC-1512
BIDD:GT0656
BPBio1_000993
BRN 2359739
BSPBio_000901
C040029
C9H17NO2
CAS-60142-96-3
CCRIS 7210
CHEBI:188316
CHEBI:42797
CHEMBL940
CI 945
CI-945
CID3446
D00332
DB00996
DDS-2003
DM-1796
DM-5689
EINECS 262-076-3
EU-0100582
G-154
G0318
G154_SIGMA
GBN
GOE 2450
Gabapen
Gabapentin
Gabapentin (JAN/USAN/INN)
Gabapentin GR
Gabapentin Hexal
Gabapentin Stada
Gabapentin [USAN:INN:BAN]
Gabapentin-ratiopharm
Gabapentina
Gabapentine
Gabapentine [INN-French]
Gabapentino
Gabapentino [INN-Spanish]
Gabapentino [Spanish]
Gabapentinum
 
Gabapentinum [INN-Latin]
Gabapetin
Go 3450
Goe-3450
HMS1570N03
HMS2089J03
HSDB 7364
Hexal brand of gabapentin
I06-0677
L000733
LS-7194
Lopac-G-154
Lopac0_000582
MLS000069358
MolPort-000-883-862
NCGC00015466-01
NCGC00015466-02
NCGC00015466-06
NCGC00015466-09
NCGC00016891-01
NCGC00021545-02
NCGC00021545-04
NCGC00021545-05
NSC742194
Neurontin
Neurontin (TN)
Novo-Gabapentin
Novo-Gabapentine
Novopharm brand of gabapentin
PMS-Gabapentin
Parke Davis brand of gabapentin
Pfizer brand of gabapentin
Pharmascience brand of gabapentin
Prestwick0_000861
Prestwick1_000861
Prestwick2_000861
Prestwick3_000861
Prestwick_151
S2133_Selleck
SMR000058311
SPBio_002822
STK598009
Serada
Stadapharm brand of gabapentin
TL8003814
Tocris-0806
UNII-6CW7F3G59X
Vultin
Warner-Lambert brand of gabapentin
[1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID
gabapentin
gabapentin (Neurontin)
gabapentina
gabapentinium
ratiopharm brand of gabapentin
5
Ketamineapproved, vet_approvedPhase 4, Phase 1, Phase 25696740-88-13821
Synonyms:
(+-)-Ketamine
(+/-)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
(+/-)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
(+/-)-Ketamine
(-)-Ketamine
(S)-(-)-Ketamine
(S)-Ketamine
(±)-ketamine
100477-72-3
2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone
2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one
2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(o-Chlorophenyl)-2-(methylamino)-cyclohexanone
2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone
33643-45-7
6740-88-1
79499-51-7
AC1L1GSH
AC1Q40UR
AKOS001053247
BRN 2216965
C07525
C13H16ClNO
CHEBI:138833
CHEBI:6121
CHEMBL742
CI 581 base
CI-581
CID3821
CLSTA 20
Calypsol
Cetamina
Cetamina [INN-Spanish]
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)- (9CI)
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+-)- (9CI)
Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+/-)- (8CI)
D08098
DB01221
 
DEA No. 7285
DL-ketamine
DivK1c_000217
EINECS 229-804-1
Esketamine
Green
IDI1_000217
KBio1_000217
KETAMINE HCL
Ketaject
Ketalar
Ketalar base
Ketamina
Ketamine (INN)
Ketamine Base
Ketamine HCL
Ketamine [INN:BAN]
Ketaminum
Ketaminum [INN-Latin]
Ketanest
Ketoject
Ketolar
Kétamine
L-Ketamine
LS-57301
MLS001331674
MolPort-001-838-070
NCGC00159480-02
NCGC00159480-03
NINDS_000217
NMDA
NSC 70151
NSC70151
SMR000238141
Special K
Special K [street name]
T385
Tekam
Tekam (TN)
UNII-690G0D6V8H
dl-Ketamine
ketamine
l-Ketamine
6
Dexmedetomidineapproved, vet_approvedPhase 4, Phase 1, Phase 259276631-46-4, 113775-47-668602, 5311068, 56032
Synonyms:
(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-alpha,2,3-trimethylbenzyl)imidazole
(+)-medetomidine
(S)-medetomidine
113775-47-6
4-[(1S)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole
4-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
AC1NSJXT
C07450
CHEBI:4466
CHEMBL778
CID5311068
D00514
DEXMEDETOMIDINE
 
Dexdor (T)
Dexmedetomidin
Dexmedetomidina
Dexmedetomidine
Dexmedetomidine (USAN/INN)
Dexmedetomidinum
Dexmédétomidine
MPV 1440
MPV-1440
Medetomidina [Spanish]
Medetomidine
Medetomidinum [Latin]
NCGC00025347-01
PRECEDEX
Precedex (TN)
Tocris-2023
ZINC04632106
7
Sevofluraneapproved, vet_approvedPhase 450828523-86-65206
Synonyms:
1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane
28523-86-6
AC-15484
AC1L1JU0
BRN 2041023
Bax 3084
C009250
C07520
C4H3F7O
CHEBI:9130
CHEMBL1200694
CID5206
D00547
DB01236
F0691
Fluoromethyl 1,1,1,3,3,3-Hexafluoroisopropyl Ether
Fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
I14-13357
LS-67851
MR6S4
 
MR_6S4
MolPort-001-775-746
NCGC00167421-01
PC4681
Sevofluran
Sevoflurane
Sevoflurane (JAN/USAN/INN)
Sevoflurane [USAN:INN:BAN:JAN]
Sevoflurano
Sevoflurano [INN-Spanish]
Sevofluranum
Sevofluranum [INN-Latin]
Sevofrane
Sevorane
Sojourn
UNII-38LVP0K73A
Ultane
Ultane (TN)
ZINC01530810
fluoromethyl hexafluoroisopropyl ether
fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
sevoflurane
8
Alfentanilapproved, illicitPhase 43771195-58-951263
Synonyms:
5-26-13-00110 (Beilstein Handbook Reference)
70879-28-6 (hydrochloride)
71195-58-9
AC1L1ARM
AC1Q6F0S
ALFENTANIL
Alfenta
Alfentanil (INN)
Alfentanil [INN:BAN]
Alfentanilum
Alfentanilum [INN-Latin]
Alfentanyl
BRN 1188293
C08005
CHEBI:127190
CHEBI:2569
 
CHEMBL634
CID51263
D07122
DB00802
DEA No. 9737
HSDB 6789
L001231
LS-119259
MolPort-004-285-887
N-(1-(2-(4-Ethyl-4,5-dihydro-5-oxotetrazolyl)ethyl)-4-(methoxymethyl)-4-piperidyl)-N-phenylpropionamid
N-(1-(2-(4-Ethyl-4,5-dihydro-5-oxotetrazolyl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilid
N-(1-(2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide
N-[1-[2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl]-4-(methoxymethyl)-4-piperidyl]propionanilide
N-[1-[2-(4-ethyl-5-oxotetrazol-1-yl)ethyl]-4-(methoxymethyl)piperidin-4-yl]-N-phenylpropanamide
N-{1-[2-(4-ethyl-5-oxo-4,5-dihydro-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)piperidin-4-yl}-N-phenylpropanamide
N-{1-[2-(4-ethyl-5-oxo-4,5-dihydro-1H-tetrazol-1-yl)ethyl]-4-[(methyloxy)methyl]piperidin-4-yl}-N-phenylpropanamide
Rapifen (TN)
UNII-1N74HM2BS7
9
Lidocaineapproved, vet_approvedPhase 41317137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Cuivasil
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
 
LS-805
Lanabiotic
Leostesin
Lida-Mantle
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
Lignocaine
Lignocainum
Lingocaine
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-MPF
Xylocaine-MPF with Glucose
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
10
Epinephrineapproved, vet_approvedPhase 498551-43-45816
Synonyms:
(-)-(R)-Epinephrine
(-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-dihydroxy-a-[(methylamino)methyl]-Benzyl alcohol
(-)-3,4-dihydroxy-alpha-[(methylamino)methyl]-Benzyl alcohol
(-)-Adrenalin
(-)-Adrenaline
(-)-Epinephrine
(-)-R-Epinephrine
(R)-(-)-Adnephrine
(R)-(-)-Adrenaline
(R)-(-)-Epinephrine
(R)-(-)-Epirenamine
(R)-(−)-adrenaline
(R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
(R)-4-[1-hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
(R)-Adrenaline
(R)-Epinephrine
(−)-adrenaline
02252_FLUKA
1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
1-Adrenalin
1-Epinephrine
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol
4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
51-43-4
51-43-4 (FREE BASE)
51028-73-0
A0173
AC-13188
AC1L1L7B
ADR ADRENALINE
ADROP
AI3-19015
Adnephrine
Adrenal
Adrenalin
Adrenalin (TN)
Adrenalin in Oil
Adrenalin-Medihaler
Adrenalina
Adrenalina [DCIT]
Adrenaline
Adrenaline (JP15)
Adrenaline/Epinephrine
Adrenalinum
Adrenamine
Adrenan
Adrenapax
Adrenasol
Adrenatrate
Adrenine
Adrenodis
Adrenohorma
Adrenosan
Adrenutol
Adrin
Adrine
Ana-Guard
Ana-Kit
Antiasthmatique
Asmatane Mist
Asthma meter mist
Asthma-nefrin
Asthmahaler Mist
Asthmanefrin
Astmahalin
Astminhal
BIDD:GT0119
Balmadren
Bernarenin
Biorenine
Bosmin
Brevirenin
Bronkaid
Bronkaid Mist
Bronkaid Suspension Mist
Bupivacaine Hcl and Epinephrine
C00788
CCRIS 4812
CHEBI:28918
CHEMBL679
CID5816
Chelafrin
Citanest Forte
Corisol
D-Epifrin
D-Epinephrine
D00095
DB00668
Drenamist
Dylephrin
Dyspne-Inhal
E4250_SIGMA
EINECS 200-098-7
EPI E Z PEN JR
EPIPEN E Z PEN
EPIPEN JR
Epi EZ Pen Jr
Epifrin
Epiglaufrin
Epinefrin
Epinefrin [Czech]
Epinefrina
Epinefrina [INN-Spanish]
Epinephran
Epinephrin
Epinephrine
Epinephrine (USP)
Epinephrine (USP/INN)
Epinephrine [USAN:INN:JAN]
Epinephrine hydrochloride
Epinephrinum
Epinephrinum [INN-Latin]
Epipen
Epipen (TN)
Epipen Auto-Injector
Epipen EZ Pen
Epipen Jr.
Epipen Jr. Auto-Injector
Epirenamine
Epirenan
Epirenin
Epitrate
Eppy
Esphygmogenina
Exadrin
 
Glaucon
Glaucosan
Glauposine
Glycirenan
HSCI1_000215
HSDB 4289
Haemostasin
Haemostatin
Hektalin
Hemisine
Hemostasin
Hemostatin
Hypernephrin
Hyporenin
IOP
Intranefrin
Iontocaine
Isoptoepinal
Kidoline
L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
L-Adrenaline
L-Adrenaline Base
L-Epinehphrine
L-Epinephrine
L-Epirenamine
L-Methylaminoethanolcatechol
L-epinephrine
LS-156
Levo-Methylaminoethanolcatechol
Levoadrenaline
Levoepinephrine
Levorenen
Levorenin
Levorenine
Levoreninum
Lopac-E-4642
Lyodrin
Lyophrin
Medihaler-Epi
Metanephrin
Methylaminoethanolcatechol
Methylarterenol
Micronefrin
Micronephrine
MolPort-002-051-368
Mucidrina
Myosthenine
Mytrate
NCGC00015417-01
NCGC00142615-01
NCGC00142615-03
NCGC00142615-04
NCGC00142615-05
NCGC00142615-06
NCGC00142615-07
NSC 62786
NSC62786
Nephridine
Nieraline
PDSP1_001120
PDSP2_001104
Paranephrin
Primatene
Primatene Mist
R-(-)-Epinephrine
R-Adrenaline
RCRA waste no. P042
Racemic Epinephrine
Racepinephrine
Rcra waste number P042
Renagladin
Renaglandin
Renaglandulin
Renaleptine
Renalina
Renoform
Renostypricin
Renostypticin
Renostyptin
SMP1_000227
ST069368
SUS-PHRINE SULFITE-FREE
Scurenaline
Septocaine
Simplene
Sindrenina
Soladren
Sphygmogenin
Stryptirenal
Styptirenal
Supracapsulin
Supradin
Supranefran
Supranephrane
Supranephrine
Supranol
Suprarenaline
Suprarenin
Suprel
Surenine
Surrenine
Sus-Phrine
Sus-phrine
Susphrine
Sympathin I
Takamina
Takamine
Tokamina
Tonogen
Twinject
Twinject 0.15
Twinject 0.3
Twinject 0.30
UNII-YKH834O4BH
Vaponefrin
Vasoconstrictine
Vasoconstrictor
Vasodrine
Vasoton
Vasotonin
adrenaline
bmse000316
d-Adrenaline
epinephrine
l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
l-Adrenalin
l-Adrenaline
l-Epinephine
l-Epinephrine (synthetic)
l-Epirenamine
l-Methylaminoethanolcatechol
levoepinephrine
nchembio747-comp9
11
VortioxetineapprovedPhase 464508233-74-79966051
Synonyms:
4-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium
 
BRINTELLIX
vortioxetine cation
12Hypnotics and SedativesPhase 4, Phase 3, Phase 2, Phase 12616
13GABA AgentsPhase 4, Phase 3, Phase 2, Phase 11684
14GABA ModulatorsPhase 4, Phase 3, Phase 2, Phase 1904
15Tranquilizing AgentsPhase 4, Phase 3, Phase 2, Phase 14265
16Antiparkinson AgentsPhase 4, Phase 11574
17Antidepressive AgentsPhase 4, Phase 3, Phase 12736
18Anti-Anxiety AgentsPhase 4, Phase 3, Phase 2, Phase 11885
19Peripheral Nervous System AgentsPhase 4, Phase 1, Phase 223689
20Central Nervous System DepressantsPhase 4, Phase 3, Phase 2, Phase 113403
21Serotonin AgentsPhase 4, Phase 3, Phase 13156
22Serotonin Uptake InhibitorsPhase 4, Phase 3, Phase 11587
23Adjuvants, AnesthesiaPhase 4, Phase 3, Phase 2, Phase 11674
24
SerotoninPhase 4, Phase 3, Phase 1362750-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
25Psychotropic DrugsPhase 4, Phase 3, Phase 2, Phase 16430
26Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 118340
27Neurotransmitter Uptake InhibitorsPhase 4, Phase 3, Phase 2, Phase 13521
28Muscarinic AntagonistsPhase 4, Phase 11166
29ParasympatholyticsPhase 4, Phase 11085
30Cholinergic AntagonistsPhase 4, Phase 11706
31Anesthetics, GeneralPhase 4, Phase 3, Phase 2, Phase 12934
32Anesthetics, IntravenousPhase 4, Phase 3, Phase 2, Phase 12538
33AnestheticsPhase 4, Phase 3, Phase 2, Phase 19596
34Antidepressive Agents, Second-GenerationPhase 4, Phase 3, Phase 11311
35Cholinergic AgentsPhase 4, Phase 13992
36Autonomic AgentsPhase 4, Phase 110150
37NarcoticsPhase 43646
38Platelet Aggregation InhibitorsPhase 42516
39Antimanic AgentsPhase 4814
40
gamma-Aminobutyric AcidPhase 424156-12-2119
Synonyms:
3-Carboxypropylamine
4-Aminobutanoate
4-Aminobutanoic acid
4-Aminobutyrate
4-Aminobutyric acid
Aminalon
GABA
Gaballon
Gamarex
Gammalon
Gammalone
Gammar
Gammasol
 
Mielogen
Mielomade
Omega-Aminobutyrate
Omega-Aminobutyric acid
Piperidate
Piperidic acid
Piperidinate
Piperidinic acid
gamma Aminobutyrate
gamma Aminobutyric acid
gamma-Aminobutyrate
gamma-Aminobutyric acid
w-Aminobutyrate
w-Aminobutyric acid
41calcium channel blockersPhase 41985
42AnticonvulsantsPhase 42695
43Calcium, DietaryPhase 45713
44Excitatory Amino Acid AntagonistsPhase 4, Phase 1, Phase 21347
45Anesthetics, InhalationPhase 4684
46Adrenergic AgonistsPhase 4, Phase 2, Phase 13027
47Adrenergic alpha-2 Receptor AgonistsPhase 4, Phase 2, Phase 1980
48Anesthetics, DissociativePhase 4, Phase 1, Phase 2544
49AnalgesicsPhase 4, Phase 1, Phase 211733
50Analgesics, Non-NarcoticPhase 4, Phase 1, Phase 26501

Interventional clinical trials:

(show top 50)    (show all 75)
idNameStatusNCT IDPhase
1Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and AdolescentsCompletedNCT01160588Phase 4
2Dexmedetomidine Premedication in ChildrenCompletedNCT03174678Phase 4
3Intranasal Dexmedetomidine vs Midazolam-ketamine Combination for Premedication of Pediatric PatientsCompletedNCT02072083Phase 4
4The Effect of Parental Presence on Dental FearCompletedNCT02619981Phase 4
5Sevoflurane Induced Emergence AgitationCompletedNCT02022488Phase 4
6Plasma Gabapentin Concentration During and Following Cardiac BypassCompletedNCT01022736Phase 4
7A Comparison of Two Doses of Intranasal Dexmedetomidine for Premedication in ChildrenRecruitingNCT02459509Phase 4
8Ketamine Infusion for Adolescent Depression and AnxietyRecruitingNCT02579928Phase 4
9Pattern Separation, Brain Derived Neurotrophic Factors, and Mechanisms of VortioxetineRecruitingNCT02969876Phase 4
10Vilazodone for Separation Anxiety DisorderActive, not recruitingNCT01999920Phase 4
11Developing New Clinical Management StrategiesActive, not recruitingNCT02082392Phase 4
12Sedation in the Intensive Care UnitUnknown statusNCT00221520Phase 3
13Treatment for Anxiety in ChildrenCompletedNCT00000389Phase 3
14Computerized Cognitive Behavioral Therapy for Childhood Anxiety in Community Health CentersCompletedNCT01416805Phase 3
15Child and Adolescent Anxiety Disorders (CAMS)CompletedNCT00052078Phase 3
16Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum DisordersCompletedNCT01178385Phase 2, Phase 3
17A Study of Pediatric Patients With Attention Deficit/Hyperactivity DisorderCompletedNCT00922636Phase 2, Phase 3
18A Comparison of Midazolam and Zolpidem as Oral Premedication in ChildrenCompletedNCT02096900Phase 3
19Reduction of Preoperative Anxiety in Children: Electronic Tab vs MidazolamCompletedNCT02192710Phase 3
20Study to See if Microcoil Insertion Reduces the Rate of Open Thoracotomy for Removal of Lung NodulesCompletedNCT01028417Phase 3
21Psychotherapy for Anxiety in Children With Autism Spectrum DisorderRecruitingNCT02028247Phase 3
22Treatment Study for Rural Latino Youth With AnxietyUnknown statusNCT01491880Phase 1, Phase 2
23SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)CompletedNCT01470469Phase 2
24Modular Cognitive Behavioral Therapy for the Treatment of Child Anxiety Disorders in Elementary School SettingsCompletedNCT00569829Phase 2
25Effects of Parental Behavior on Child Anxiety RegulationCompletedNCT00593515Phase 2
26Effectiveness Study of CBT for Anxiety in ChildrenCompletedNCT00586586Phase 2
27Effectiveness of Cognitive Behavioral Therapy (CBT) for Child Anxiety Disorders in Community Clinics in NorwayCompletedNCT00735995Phase 2
28A GameBoy as a Distraction Before Surgery in ChildrenCompletedNCT00176670Phase 2
29Brief Behavioral Treatment for Anxiety in Young ChildrenCompletedNCT02051192Phase 1, Phase 2
30Premedication With Nebulized Ketamine,Dexmedetomidine Versus Midazolam in Oncologic Preschool ChildrenRecruitingNCT02935959Phase 1, Phase 2
31Cipralex® for Anxiety Disorders in AdolescentsUnknown statusNCT01293838Phase 1
32A Research Study of How Teens With and Without an Anxiety Disorder Make DecisionsCompletedNCT00104195Phase 1
33G-CSF to Treat Crohn's DiseaseCompletedNCT00025805Phase 1
34Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in ChildrenUnknown statusNCT01687764
35Comorbidity Between Balance and Childhood AnxietyUnknown statusNCT00599742
36Effectiveness of Music TherapyUnknown statusNCT01040611
37Assessing Different Methods of Anxiety Care in Pediatric SettingsUnknown statusNCT00769925
38TAFF-Psychological Treatment of Separation Anxiety DisorderCompletedNCT00255112
39Cartoon Distraction and Parental Presence on Anxiety in Pediatric AnesthesiaCompletedNCT02027844
40Internet-delivered Treatment for Children With Anxiety Disorders in a Rural Area; an Open Trial in a Clinical SettingCompletedNCT02306356
41Transdisciplinary Studies of CBT for Anxiety in Youth: Child Anxiety Treatment StudyCompletedNCT00774150
42Sleep, Mood, and Behavior StudyCompletedNCT00787397
43Treatment of Youth With ADHD and AnxietyCompletedNCT00012584
44Internet-delivered Cognitive Behavior Therapy (CBT) for Children Age 8-12 Years With Anxiety DisordersCompletedNCT01533402
45Ventilatory Physiology in Children at Risk for AnxietyCompletedNCT00101777
46Reward-Related Processes and Brain FunctionCompletedNCT00029588
47Computer- Assisted Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum DisordersCompletedNCT01565629
48Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With AutismCompletedNCT01563003
49CO2 Inhalation and Risk for Panic DisorderCompletedNCT00930657
50Youth Mayo Clinic Anxiety Coach Pilot StudyCompletedNCT02205177

Search NIH Clinical Center for Separation Anxiety Disorder

Genetic Tests for Separation Anxiety Disorder

About this section

Anatomical Context for Separation Anxiety Disorder

About this section

MalaCards organs/tissues related to Separation Anxiety Disorder:

36
Eye

Publications for Separation Anxiety Disorder

About this section

Articles related to Separation Anxiety Disorder:

(show top 50)    (show all 86)
idTitleAuthorsYear
1
Adult separation anxiety disorder in complicated grief: an exploratory study on frequency and correlates. (27683967)
2017
2
The DSM-5 Dimensional Anxiety Scales in a Dutch non-clinical sample: psychometric properties including the adult separation anxiety disorder scale. (27378317)
2016
3
The separation of adult separation anxiety disorder. (27503572)
2016
4
Can separation anxiety disorder escape its attachment to childhood? (27265693)
2016
5
Separation Anxiety Disorder in School-Age Children: What Health Care Providers Should Know. (28012800)
2016
6
Why are we still missing adult separation anxiety disorder in clinical practice? (27343899)
2016
7
Associations of adult separation anxiety disorder with conflict-related trauma, ongoing adversity, and the psychosocial disruptions of mass conflict among West Papuan refugees. (26752442)
2016
8
Adult separation anxiety disorder: accepted but little understood. (25572307)
2015
9
Dependent personality, separation anxiety disorder and other anxiety disorders in OCD. (26542617)
2015
10
Psychopathology among parents of children and adolescents with separation anxiety disorder. (25605571)
2015
11
Pediatric-Onset and Adult-Onset Separation Anxiety Disorder Across Countries in the World Mental Health Survey. (26046337)
2015
12
Separation anxiety disorder from the perspective of DSM-5: clinical investigation among subjects with panic disorder and associations with mood disorders spectrum. (25704393)
2015
13
Biased attention to threat in paediatric anxiety disorders (generalized anxiety disorder, social phobia, specific phobia, separation anxiety disorder) as a function of 'distress' versus 'fear' diagnostic categorization. (23591000)
2014
14
The right amygdalar tumor presenting with symptoms of separation anxiety disorder (SAD): a case report. (24593853)
2014
15
Patterns of family identification and self-congruence in childhood separation anxiety disorder. (23751201)
2014
16
Separation anxiety disorder across the lifespan: DSM-5 lifts age restriction on diagnosis. (25453710)
2014
17
The relationships among separation anxiety disorder, adult attachment style and agoraphobia in patients with panic disorder. (25218272)
2014
18
The effective comparison between emotion-focused cognitive behavioral group therapy and cognitive behavioral group therapy in children with separation anxiety disorder. (24949029)
2014
19
Early-life risk factors for panic and separation anxiety disorder: Insights and outstanding questions arising from human and animal studies of CO2 sensitivity. (24793177)
2014
20
Separation anxiety disorder in adult patients with obsessive-compulsive disorder: Prevalence and clinical correlates. (24908152)
2014
21
The efficacy of a family-based cognitive-behavioral treatment for separation anxiety disorder in children aged 8-13: a randomized comparison with a general anxiety program. (23607501)
2013
22
A randomized controlled trial of the child anxiety multi-day program (cAMP) for separation anxiety disorder. (23053618)
2013
23
The Diagnostic Utility of Separation Anxiety Disorder Symptoms: An Item Response Theory Analysis. (23963543)
2013
24
Responses to voluntary hyperventilation in children with separation anxiety disorder: implications for the link to panic disorder. (24064331)
2013
25
Adult separation anxiety disorder in DSM-5. (23673209)
2013
26
Separation anxiety disorder: lumping or splitting? (23493754)
2013
27
Separation anxiety disorder in adults: is the neglect real? (23382511)
2013
28
Overlap of symptom domains of separation anxiety disorder in adulthood with panic disorder-agoraphobia. (23247205)
2013
29
DSM-5 allows separation anxiety disorder to grow up. (23293308)
2013
30
Let's not abandon separation anxiety disorder in adulthood. (23901150)
2013
31
Looking for balance between promoting adult separation anxiety disorder and overlooking it. (23901151)
2013
32
Beliefs regarding child anxiety and parenting competence in parents of children with separation anxiety disorder. (22922077)
2013
33
Hypersensitivity to 35% carbon dioxide in patients with adult separation anxiety disorder. (22542862)
2012
34
Separation anxiety disorder in children: disorder-specific responses to experimental separation from the mother. (21923807)
2012
35
Separation anxiety disorder increases among neonatal intensive care unit graduates. (21819341)
2012
36
The relationship between adult separation anxiety disorder and complicated grief in a cohort of 454 outpatients with mood and anxiety disorders. (22832169)
2012
37
Does the vigilance-avoidance gazing behavior of children with separation anxiety disorder change after cognitive-behavioral therapy? (22466517)
2012
38
Childhood separation anxiety disorder and adult onset panic attacks share a common genetic diathesis. (22461084)
2012
39
Temperament and character dimensions of patients with adult separation anxiety disorder. (22440427)
2012
40
Brief report--associations of personality disorder with early separation anxiety in patients with adult separation anxiety disorder. (21309628)
2011
41
Separation anxiety disorder in OCD. (21308883)
2011
42
Children suffering from separation anxiety disorder (SAD) show increased HPA axis activity compared to healthy controls. (20870248)
2011
43
Disorder-specific cognitive-behavioral therapy for separation anxiety disorder in young children: a randomized waiting-list-controlled trial. (21494062)
2011
44
Early predictors of separation anxiety disorder: early stranger anxiety, parental pathology and prenatal factors. (21847002)
2011
45
DSM-IV criteria for childhood separation anxiety disorder: informant, age, and sex differences. (20675099)
2010
46
Adult separation anxiety disorder among war-affected Bosnian refugees: comorbidity with PTSD and associations with dimensions of trauma. (20135680)
2010
47
Adult separation anxiety disorder: a disorder comes of age. (20552302)
2010
48
Association of DRD4 polymorphism with severity of oppositional defiant disorder, separation anxiety disorder and repetitive behaviors in children with autism spectrum disorder. (20731709)
2010
49
The prevalence and correlates of adult separation anxiety disorder in an anxiety clinic. (20219138)
2010
50
Vigilance and avoidance of threat in the eye movements of children with separation anxiety disorder. (19813086)
2010

Variations for Separation Anxiety Disorder

About this section

Expression for genes affiliated with Separation Anxiety Disorder

About this section
Search GEO for disease gene expression data for Separation Anxiety Disorder.

Pathways for genes affiliated with Separation Anxiety Disorder

About this section

GO Terms for genes affiliated with Separation Anxiety Disorder

About this section

Cellular components related to Separation Anxiety Disorder according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1MHC class I protein complexGO:00426129.9HLA-A, HLA-B

Biological processes related to Separation Anxiety Disorder according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1regulation of dopamine metabolic processGO:004205310.6DRD4, SLC6A3
2antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independentGO:000248010.4HLA-A, HLA-B
3protection from natural killer cell mediated cytotoxicityGO:004227010.4HLA-A, HLA-B
4response to organic cyclic compoundGO:00140709.3OXT, PRL, SLC6A3

Molecular functions related to Separation Anxiety Disorder according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1dopamine bindingGO:003524010.6DRD4, SLC6A3
2hormone activityGO:00051798.7CORT, OXT, PRL

Sources for Separation Anxiety Disorder

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet